Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_assertion type Assertion NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_head.
- NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_assertion description "[Moreover, we found a favorable clinical outcome in patients expressing fusion genes AML1-ETO or PMLRARA in contrast to an adverse clinical outcome with few remissions and death in AML patients with MLL, -5q/?-5 and -7q/?7-.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_provenance.
- NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_assertion evidence source_evidence_literature NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_provenance.
- NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_assertion SIO_000772 26299742 NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_provenance.
- NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_assertion wasDerivedFrom befree-2016 NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_provenance.
- NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_assertion wasGeneratedBy ECO_0000203 NP1293084.RAGiOFr-jaAVlv2WFvyQ0bNNSVN8IhFQdQkzXRy6MZwOI130_provenance.